InvestorsHub Logo

jomama9231

04/15/21 10:10 PM

#335546 RE: Lemmiwinks #335544

Well. They saw CVT. Portal vein thrombosis and pes dvts mostly through immune mediated thrombocytopenia. Similar mechanism to heparin induced thrombocytopenia. Should be looked into and followed but not announced over 6-7 people over millions that have received it. We probably ruined our chances at vaccinating the hesitant folks over an incidental finding or real yet extremely rare finding.

sts66

04/17/21 2:00 PM

#335786 RE: Lemmiwinks #335544

IIRC those 6 people had CVTs - numbers for PVTs (or DVTs?) was 22 for JNJ, can't find the link right now - and appears there's a link between the vaccine an "the pill", as it occurs mostly in women aged 25-40. Still, the risk is about as low as your chance of getting hit by lightning. I'd refuse that one just because it's much inferior to mRNA vaccines, JNJ's trials had a much lower bar set for the PE, and despite the lower bar were still 20% behind PFE and MRNA in efficacy.